Search results
Showing 121 to 124 of 124 results for duty of care
This guide provides an overview of the principles and methods of health technology assessment and appraisal within the context of the NICE appraisal process
Ledipasvir–sofosbuvir for treating chronic hepatitis C (TA363)
Evidence-based recommendations on ledipasvir–sofosbuvir (Harvoni) for treating some types (genotypes) of chronic hepatitis C.
Increasing the capacity of our technology appraisals - the proportionate way
Jenniffer Prescott describes how we are trialling a proportionate approach to technology appraisals, which we expect will increase our capacity by 20% from 2023/24.
NICE's deputy chief executive, Jonathan Benger, talks about our new approach to prioritisation.